Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects
- 1 May 2004
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 173 (3-4) , 383-390
Abstract
Rationale 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a potent and selective serotonin neurotoxin whose use is growing among adolescents. Although cognitive deficits among adult MDMA users are well documented, little is known of the cognitive and brain functional sequelae of MDMA use during adolescence. Objective We tested for evidence of cognitive deficits and changes in brain function in a pilot sample of adolescent MDMA users, who were compared with adolescent non-users of MDMA. Methods Selective and divided attention and verbal working memory were examined in six adolescent MDMA users and six non-users of MDMA who were similar in age, gender, IQ, and other substance use. Brain function was assessed during performance of the working memory task using functional magnetic resonance imaging (fMRI). Results MDMA users had significantly prolonged reaction times during tests of selective and divided attention, and failed to deactivate the left hippocampus normally during high verbal working memory load. Conclusions MDMA use in adolescence may be associated with cognitive impairments and dysfunction of inhibitory circuits within the hippocampus. Further work is urgently needed to delineate the developmental impact and long-term functional and clinical significance of MDMA use during adolescence.Keywords
This publication has 63 references indexed in Scilit:
- Cognitive Performance of MDMA-Treated Rhesus Monkeys, Sensitivity to Serotonergic ChallengeNeuropsychopharmacology, 2002
- The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human BrainNeuropsychopharmacology, 2002
- Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PETNuclear Medicine Communications, 2001
- The Functional Neural Architecture of Components of Attention in Language-Processing TasksNeuroImage, 2001
- No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography StudyJournal of Clinical Psychopharmacology, 2001
- Is the Use of Ecstasy and Hallucinogens Increasing?European Addiction Research, 1998
- Modeling for Intergroup Comparisons of Imaging DataNeuroImage, 1996
- Detectability of words and nonwords in two kinds of noiseThe Journal of the Acoustical Society of America, 1988
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987
- An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the ratJournal of Comparative Neurology, 1978